Nadstawek J, Mallmann P, Lauven P M, Koenig A
Institut für Anästhesiologie, Rheinischen Friedrich-Wilhelms-Universität, Bonn.
Anasth Intensivther Notfallmed. 1989 Oct;24(5):289-92.
We investigated in vitro the influence of flunitrazepam concentrations ranged between 10 and 140 ng/ml on immunological parameters by using the rosette-inhibition-test and the lymphocyte-transformation-test. After addition of 30 ng/ml flunitrazepam, which is in accordance with a threshold concentration of 1 mg flunitrazepam after intravenous injection, we saw a significant decrease of the positive cells in the rosette-inhibition-test. In higher concentrations no significant changes could be observed. By the lymphocyte-transformation-test no significant evidence of immunodepression could be demonstrated in concentration usually achieved during anaesthesia or possibly after long term application in intensive care unit, independent of the used mitogenes. Thus, flunitrazepam demonstrates no immunosuppressive effect in concentrations achieved during anaesthesia or in intensive care unit as could be observed by tests of cellular immune competence. However, one has to take into consideration that only parts of the immunesystem could be examined with these tests and in vivo-investigations have to verify these results.
我们通过玫瑰花结抑制试验和淋巴细胞转化试验,在体外研究了浓度介于10至140纳克/毫升之间的氟硝西泮对免疫参数的影响。添加30纳克/毫升氟硝西泮后(这与静脉注射1毫克氟硝西泮后的阈值浓度一致),我们观察到玫瑰花结抑制试验中阳性细胞显著减少。在更高浓度下未观察到显著变化。通过淋巴细胞转化试验,在麻醉期间通常达到的浓度或重症监护病房长期应用后可能达到的浓度下,无论使用何种促有丝分裂原,均未发现免疫抑制的显著证据。因此,从细胞免疫能力测试可以看出,氟硝西泮在麻醉期间或重症监护病房达到的浓度下未表现出免疫抑制作用。然而,必须考虑到这些测试只能检查免疫系统的部分内容,体内研究必须验证这些结果。